GGrantIndex
← Leaderboards

Krishna Singh

Boston Medical Center

$2,209,722
Attributed
$2,209,722
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $423.2K · FY200525
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,209,722 · 5
VA$0 · 3

By mechanism

R01$1,004,276 · 2
R21$782,250 · 2
R15$423,196 · 1
I01$0 · 3

Top collaborators

No co-investigators on record.

Most similar at Boston Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Apoptosis

Research focus

ApoptosisAdultPlayIn VivoIn VitroHeartSignal TransductionHeart FailureVentricular RemodelingCardiac MyocytesTreatment StrategyMyocardial InfarctionVeteransKnockout MiceMyocardiumMolecularNovel StrategiesBiochemicalCardiacMuscle CellsProteinsCessation Of LifePathway InteractionsFibrosis

Grant awards (25)

Investigation of therapeutic potential of exogenous ubiquitin following myocardial ischemia/reperfusion injury$0
I01 · FY2025 · VA · contact PI
Investigation of therapeutic potential of exogenous ubiquitin following myocardial ischemia/reperfusion injury$0
I01 · FY2023 · VA · contact PI
Investigation of therapeutic potential of exogenous ubiquitin following myocardial ischemia/reperfusion injury$0
I01 · FY2022 · VA · contact PI
Gender-specific Role of ATM in the Heart$423,196
R15 · FY2021 · HL · contact PI
Investigation of therapeutic potential of exogenous ubiquitin following myocardial ischemia/reperfusion injury$0
I01 · FY2021 · VA · contact PI
Investigation of therapeutic potential of exogenous ubiquitin following myocardial ischemia/reperfusion injury$0
I01 · FY2020 · VA · contact PI
Investigation of therapeutic potential of exogenous ubiquitin following myocardial ischemia/reperfusion injury$0
I01 · FY2019 · VA · contact PI
Osteopontin: role in myocyte apoptosis and myocardial function$0
I01 · FY2017 · VA · contact PI
Osteopontin: role in myocyte apoptosis and myocardial function$0
I01 · FY2016 · VA · contact PI
Osteopontin: role in myocyte apoptosis and myocardial function$0
I01 · FY2015 · VA · contact PI
Osteopontin: role in myocyte apoptosis and myocardial function$0
I01 · FY2014 · VA · contact PI
ER stress: role in myocyte apoptosis and myocardial remodeling$0
I01 · FY2013 · VA · contact PI
ER stress: role in myocyte apoptosis and myocardial remodeling$0
I01 · FY2012 · VA · contact PI
ER stress: role in myocyte apoptosis and myocardial remodeling$0
I01 · FY2011 · VA · contact PI
ER stress: role in myocyte apoptosis and myocardial remodeling$0
I01 · FY2011 · VA · contact PI
Extracellular ubiquitin: role in myocyte apoptosis and myocardial remodeling$178,750
R21 · FY2010 · HL · contact PI
Extracellular ubiquitin: role in myocyte apoptosis and myocardial remodeling$213,000
R21 · FY2009 · HL · contact PI
Role of ATM in Cardiac Myocyte Loss and Myocardial Remodeling$177,500
R21 · FY2009 · HL · contact PI
Role of ATM in Cardiac Myocyte Loss and Myocardial Remodeling$213,000
R21 · FY2008 · HL · contact PI
Molecular Signals Against Beta-AR-Stimulated Apoptosis$245,687
R01 · FY2005 · HL
Molecular Signals Against Beta-AR-Stimulated Apoptosis$244,357
R01 · FY2004 · HL
Molecular Signals Against Beta-AR-Stimulated Apoptosis$243,065
R01 · FY2003 · HL
Molecular Signals Against Beta-AR-Stimulated Apoptosis$241,811
R01 · FY2002 · HL
OSTEOPONTIN IN HEART &ITS ROLE IN MYOCARDIAL REMODELING$27,156
R01 · FY2001 · HL
OSTEOPONTIN IN HEART &ITS ROLE IN MYOCARDIAL REMODELING$2,200
R01 · FY2000 · HL